Loading…
Accuray Incorporated is projected to rise to $0.2788 by 2027, a +16% move from its current price of $0.2413. ARAY is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/12/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 13 | $0.2284 | $0.2414 | $0.2551 | +0.02% |
| Jul 14 | $0.2232 | $0.2414 | $0.2611 | +0.05% |
| Jul 15 | $0.2194 | $0.2415 | $0.2658 | +0.07% |
| Jul 16 | $0.2162 | $0.2415 | $0.2698 | +0.09% |
| Jul 17 | $0.2134 | $0.2416 | $0.2734 | +0.11% |
| Jul 18 | $0.211 | $0.2416 | $0.2767 | +0.14% |
| Jul 19 | $0.2087 | $0.2417 | $0.2798 | +0.16% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $0.2087 | $0.2417 | $0.2798 | +0.16% |
| Week 2 | $0.1968 | $0.2421 | $0.2978 | +0.32% |
| Week 3 | $0.1881 | $0.2425 | $0.3125 | +0.48% |
| Week 4 | $0.1812 | $0.2429 | $0.3256 | +0.64% |
| Week 5 | $0.1753 | $0.2432 | $0.3376 | +0.80% |
| Week 6 | $0.1702 | $0.2436 | $0.3488 | +0.97% |
| Week 7 | $0.1656 | $0.244 | $0.3596 | +1.13% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Accuray Incorporated engages in the design, development, manufacture, and sale of radiosurgery and radiation therapy systems for the treatment of tumors in the United States, Canada, Latin America, Asia, Australia, New Zealand, Europe, the Middle East, India, Africa, Japan, and China. The company offers the CyberKnife platform, a robotic stereotactic radiosurgery and stereotactic body radiation therapy system used for the treatment of primary and metastatic tumors outside the brain, including tumors on or near the spine and in the breast, kidney, liver, lung, pancreas, and prostate. It also provides the TomoTherapy platform, including the Radixact System, which allows for integrated radiation treatment planning, delivery, and data management, enabling clinicians to deliver ultra-precise treatments to approximately 50 patients per day; iDMS data management system, a fully integrated treatment planning and data management systems; and Accuray precision treatment planning system, a treatment planning and data management systems.
In addition, the company offers post-contract customer support, installation, training, and other professional services. Accuray Incorporated was incorporated in 1990 and is headquartered in Madison, Wisconsin.
Accuray Incorporated (ARAY) is a healthcare company that designs and markets radiosurgery and radiation therapy systems. The stock is currently priced at $0.2413 with a market cap of $28.71M and a rank of 4742. The current price sits within a broader technical context that includes a bearish sentiment and defined support/resistance levels.
The long-range forecast presents a varied path from neutral to bullish over time, with meaningful upside potential in later years but no guarantees.
A major floor 50.3% below — a decisive break under it would weaken the trend.
Price is testing support right now (0.5% away) — a key level to hold.
The nearest ceiling, 74.1% above — a clean break opens room to run.
A major ceiling 119.6% above — clearing it would confirm fresh momentum.
Key ARAY support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of ARAY market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $0.254 | Sell | $0.2522 | Sell |
| MA 10 | $0.256 | Sell | $0.264 | Sell |
| MA 20 | $0.294 | Sell | $0.2863 | Sell |
| MA 50 | $0.3356 | Sell | $0.3361 | Sell |
| MA 100 | $0.394 | Sell | $0.4464 | Sell |
| MA 200 | $0.7629 | Sell | $0.6994 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 35.27 | Neutral |
| Stoch RSI (14) | 15.04 | Buy |
| CCI (20) | -94.74 | Neutral |
| Williams %R (14) | -100.00 | Info |
| MACD (12,26,9) | -0.00 | Sell |
| ROC (12) | -27.27 | Sell |
| Bollinger %B (20,2) | 0.16 | Neutral |
| Stochastic %K (14) | 0.00 | Buy |
| TRIX (15) | -1.05 | Sell |
| Awesome (5,34) | -0.07 | Sell |
| Ultimate (7,14,28) | 32.74 | Neutral |
| Momentum (10) | -0.08 | Sell |
| Aroon Osc (25) | -96.00 | Sell |
| Hull MA (9) | 0.25 | Sell |
| ADX (14) | 19.47 | Neutral |
| ATR (14) | 0.02 | Info |
The 30-day technical picture is bearish, with RSI14 at 40. Key moving averages are listed as SMA50 at $0.3356 and SMA200 at $0.7629. A defined support level sits at $0.24 and resistance at $0.42. The 30-day price range runs from $0.1675 to $0.3476, framing near-term volatility.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $0.24 | $0.2413 | $0.3439 | 0% | Neutral | |
| $0.2023 | $0.2788 | $0.4154 | +16% | Neutral | |
| $0.2046 | $0.2996 | $0.4758 | +24% | Bullish | |
| $0.1612 | $0.2486 | $0.4145 | +3% | Neutral | |
| $0.1387 | $0.2243 | $0.3893 | -7% | Neutral | |
| $0.1487 | $0.2513 | $0.4515 | +4% | Neutral | |
| $0.1471 | $0.2594 | $0.4806 | +8% | Neutral | |
| $0.1909 | $0.3506 | $0.6675 | +45% | Bullish | |
| $0.1977 | $0.3776 | $0.737 | +56% | Bullish | |
| $0.1664 | $0.3303 | $0.6598 | +37% | Bullish | |
| $0.2231 | $0.4958 | $1.09 | +105% | Bullish | |
| $0.2963 | $0.6585 | $1.51 | +173% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $0.24 | $0.2413 | $0.3019 | +0.00% |
| August 2026 | $0.1982 | $0.24 | $0.3028 | -0.53% |
| September 2026 | $0.2006 | $0.2464 | $0.3173 | +2.65% |
| October 2026 | $0.2119 | $0.2635 | $0.3453 | +6.93% |
| November 2026 | $0.2076 | $0.2608 | $0.3467 | -1.01% |
| December 2026 | $0.2012 | $0.2553 | $0.3439 | -2.12% |
Click any year to see its month-by-month ARAY forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
The ARAY price prediction for 2026 points to an average of $0.2413 (low $0.24, high $0.3439) — a potential gain of 0% on today's $0.2413. Price action looks broadly range-bound.
In 2027, ARAY is projected to trade between $0.2023 and $0.4154, averaging $0.2788 — a potential gain of +16% from today's $0.2413. That is up +16% on the projected 2026 average. A consolidation phase looks the most probable path here.
Accuray Incorporated's 2028 outlook centres on $0.2996, within a $0.2046 to $0.4758 range. That is up +7% on the projected 2027 average. That marks a +24% change versus current levels. Momentum favours further upside here.
By 2029, ARAY could reach as high as $0.4145, with a base case around $0.2486 and support toward $0.1612 — roughly +3% from $0.2413. A consolidation phase looks the most probable path here.
Expect ARAY to range from $0.1387 to $0.3893 through 2030. The $0.2243 average target implies a -7% move from current prices. That is -10% versus the projected 2029 average. Price action looks broadly range-bound.
The ARAY price prediction for 2031 points to an average of $0.2513 (low $0.1487, high $0.4515) — a potential gain of +4% on today's $0.2413. A consolidation phase looks the most probable path here.
In 2032, ARAY is projected to trade between $0.1471 and $0.4806, averaging $0.2594 — a potential gain of +8% from today's $0.2413. That is up +3% on the projected 2031 average. Price action looks broadly range-bound.
Accuray Incorporated's 2033 outlook centres on $0.3506, within a $0.1909 to $0.6675 range. That is up +35% on the projected 2032 average. That marks a +45% change versus current levels. Buyers look set to stay in control over this stretch.
By 2034, ARAY could reach as high as $0.737, with a base case around $0.3776 and support toward $0.1977 — roughly +56% from $0.2413. Momentum favours further upside here.
Expect ARAY to range from $0.1664 to $0.6598 through 2035. The $0.3303 average target implies a +37% move from current prices. That is -13% versus the projected 2034 average. Buyers look set to stay in control over this stretch.
The ARAY price prediction for 2040 points to an average of $0.4958 (low $0.2231, high $1.09) — a potential gain of +105% on today's $0.2413. Momentum favours further upside here.
In 2050, ARAY is projected to trade between $0.2963 and $1.51, averaging $0.6585 — a potential gain of +173% from today's $0.2413. That is up +33% on the projected 2040 average. Buyers look set to stay in control over this stretch.
Investing $1,000 in ARAY today (≈ 4,144.218815 ARAY) could be worth
$2,728.89
+$1,728.89 (+173%) by 2050 · US Dollar
Based on the average projected ARAY price of $0.66 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in ARAYwould be worth at today's price.
$1,000 invested in ARAY on Jul 10, 2025 (≈ 709.219875 ARAY) would be worth
$171.13
-$828.87 (-82.9%) today · 0.17× · US Dollar
Based on a ARAY entry price of $1.41 vs. today's $0.2413.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $0.25 | $965.2 | -3.5% |
| 1 month ago | $0.33 | $731.21 | -26.9% |
| 3 months ago | $0.39 | $618.72 | -38.1% |
| 6 months ago | $0.87 | $277.36 | -72.3% |
| 1 year ago | $1.41 | $171.13 | -82.9% |
| All time (5.0y) ago | $4.27 | $56.51 | -94.3% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our ARAY forecast.
Our base-case forecast reaches $0.48 around 2040.
Implied market cap at $0.48: $57.1M
The multi-year forecast shows a sequence of adjustments in expected price and performance. For 2026 the min is $0.24, the avg is $0.2413, and the max is $0.3443, with a 0% ROI and a neutral sentiment. In 2027 the min is $0.2027, the avg is $0.2794, and the max is $0.4165, with a 15.8% ROI and a neutral sentiment.
The 2028 forecast lists a min of $0.2041, an avg of $0.299, and a max of $0.4748, with a 23.9% ROI and a bullish sentiment. For 2029 the min is $0.1611, the avg is $0.2486, and the max is $0.4144, with a 3% ROI and a neutral sentiment. The 2030 outlook shows a min of $0.1389, an avg of $0.2247, and a max of $0.3899, with a -6.9% ROI and a neutral sentiment.
Through 2031 and 2032 the averages are $0.251 and $0.2598 respectively, with modest ROIs (4% and 7.7%) and neutral sentiment. 2033 and 2034 shift to bullish momentum (avg $0.3509 and $0.3771; max $0.6681 and $0.7361; ROIs 45.4% and 56.3%). 2035 remains bullish (avg $0.3306; max $0.6604; ROI 37%).
The horizon broadens into 2040 with an avg of $0.4952, a min of $0.2229, a max of $1.09, and a 105.2% ROI amid bullish sentiment, continuing into 2050 with an avg of $0.6593, a min of $0.2967, a max of $1.52, and a 173.2% ROI with bullish sentiment. These figures illustrate a path of fluctuating near-term performance with substantial upside potential later, but they are estimates and not guarantees.
Tap a question to reveal the answer.
2030 min: $0.1389, avg: $0.2247, max: $0.3899; ROI -6.9%; sentiment NEUTRAL.
Forecasts show a mix of neutral and bullish periods, with 2040 ROI 105.2% and 2050 ROI 173.2%, but 2030 ROI -6.9%. The outlook suggests potential upside in later years but remains uncertain and not guaranteed.
Yes. The forecasted max price in 2050 is $1.52.
In 2026 the avg forecast is $0.2413, with a 30-day range of $0.1675 to $0.3476 and a current price of $0.2413. The 2027 forecast shows a rise to an avg of $0.2794 and a max of $0.4165.
2040 min $0.2229, avg $0.4952, max $1.09; ROI 105.2%; sentiment BULLISH.
Accuray Incorporated Community Discussion
0Share your Accuray Incorporated price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.